
US funded scientists said Thursday they have devised an experimental vaccine against a common childhood illness called respiratory syncytial virus (RSV). There is currently no vaccine on the market for RSV, which is the world's second-leading killer of babies aged one month to one year, after malaria. RSV causes inflammation in the small airways of the lungs and is the most common cause of pneumonia in babies and of hospitalization of children under five. Many common diseases of childhood are now vaccine-preventable, but a vaccine against RSV infection has eluded us for decades,? said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. This work marks a major step forward," he said, citing promising animal studies that showed a wide-ranging protective effect. Planning is under way for human trials of the vaccine. The research on the vaccine and its structure-based design is described in the journal Science.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor